Equities

Bangkok Dusit Medical Services PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Bangkok Dusit Medical Services PCL

Actions
  • Price (THB)21.00
  • Today's Change0.10 / 0.48%
  • Shares traded50.79m
  • 1 Year change-9.09%
  • Beta--
Data delayed at least 15 minutes, as of Feb 09 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Institutional shareholders

3.64%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 09 Jan 2026251.98m1.59%
BlackRock Advisors (UK) Ltd.as of 09 Jan 2026103.23m0.65%
Geode Capital Management LLCas of 04 Feb 202650.68m0.32%
Schroder Investment Management Ltd.as of 31 Dec 202540.84m0.26%
DWS Investments (UK) Ltd.as of 08 Jan 202631.75m0.20%
Northern Trust Investments, Inc.(Investment Management)as of 09 Jan 202622.47m0.14%
Sjunde AP-fondenas of 28 Feb 202521.44m0.14%
State Street Global Advisors Ltd.as of 08 Jan 202620.72m0.13%
JPMorgan Asset Management (Asia Pacific) Ltd.as of 30 Sep 202519.07m0.12%
Vanguard Asset Management Ltd.as of 31 Dec 202515.85m0.10%
More ▼
Data from 28 Feb 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.